# Ashwagandha Sleep Quality Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/ashwagandha-sleep-quality-meta-analysis-evidence-review
Category: evidence-review
Summary: Ashwagandha Sleep Quality Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-06-09
Reviewed by: Migaku Evidence Review
# Ashwagandha Sleep Quality Meta-analysis: What the Evidence Says

## Quick Answer

Ashwagandha Sleep Quality Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Comparative Evaluation of Ashwagandha ( Withania somnifera ) Root Extract and Melatonin for Improving Sleep Quality in Adults: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study | randomized trial | 2 | 2026-03-27 | 10.3390/clockssleep8020015 |

## What The Sources Report

- Sleep disturbances also carry broader social and economic consequences, such as more missed workdays, reduced productivity, increased healthcare use, and a higher risk of workplace or traffic accidents. [Movva Navya (2026); evidence level 2]
- Epidemiological data show that the prevalence of sleep disturbance rises with age and is impacted by characteristics including female gender, reduced socioeconomic status, and concomitant medical conditions. [Movva Navya (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For ashwagandha sleep quality meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Movva Navya (2026). Comparative Evaluation of Ashwagandha ( Withania somnifera ) Root Extract and Melatonin for Improving Sleep Quality in Adults: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. DOI: 10.3390/clockssleep8020015. PMCID: PMC13108063. PMID: 42029558. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13108063/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.